Matthew S. Abbott - May 8, 2024 Form 4 Insider Report for Chemours Co (CC)

Role
Interim CFO
Signature
/s/ Nicole Perez Lengel, Attorney-in-Fact
Stock symbol
CC
Transactions as of
May 8, 2024
Transactions value $
$0
Form type
4
Date filed
5/10/2024, 04:03 PM
Previous filing
Mar 29, 2024
Next filing
Aug 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CC Common Stock Award $0 +11.8K +34.47% $0.00 46.1K May 8, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Stock Option (Right to Buy) Award $0 +31.6K $0.00 31.6K May 8, 2024 Common Stock 31.6K $27.50 Direct F3
transaction CC Performance Stock Option (Right to Buy) Award $0 +32.9K $0.00 32.9K May 8, 2024 Common Stock 32.9K $30.25 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025.
F2 Includes directly owned shares, restricted stock units and dividend equivalent units.
F3 These options are scheduled to vest in three equal annual installments beginning on May 8, 2025.
F4 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.